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Abstract
Introduction. Differentiated thyroid carcinoma (DTC) is a
rare childhood malignancy, as it represents 0.3–0.4% of pe-
diatric malignancies.  Papillary carcinoma is the most com-
mon type of pediatric DTC and it represents about 90% of
all DTC patients. Although rare, DTC arising from dyshor-
monogenetic goiter is the most serious complication of
congenital hypothyroidism. Case report. We presented the
development of thyroid papillary carcinoma in a 15-year-old
girl diagnosed with congenital dyshormonogenetic hypothy-
roidism at neonatal age. Considering the early initiation and
proper dosage of hormonal substitution, normal levels of
thyreotropin and thyroid hormones were achieved quickly
and maintained through a follow-up period. The girl re-
mained euthyroid and asymptomatic until 13.8 years of age,
when she presented with a large multinodular goiter. The
patient underwent total thyroidectomy. Pathological exami-
nation revealed intrathyroid microcarcinoma in the right
lobe.  Conclusion. Although differentiated thyroid carci-
noma is a rare pediatric malignancy, it is of great importance
to have a certain degree of clinical caution and provide a
multidisciplinary approach during the follow-up of patients
with dyshormonogenetic hypothyroidism.
Key words:
congenital hypothyroidism; thyroid neoplasms;
carcinoma, papillary; thiroidectomy; child; treatment
outcome; serbia.
Apstrakt
Uvod. Diferentovani karcinom štitaste žlezde (DKŠŽ) je
redak malignitet u detinjstvu i predstavlja 0,3–0,4% pedi-
jatrijskih maligniteta. Najÿešýa forma DKŠŽ je papilarni
karcinom pošto se javlja u približno 90% sluÿajeva. Iako
redak, DKŠŽ koji se javlja kod dishormonogenetske stru-
me predstavlja najozbiljniju komplikaciju kongenitalne hi-
potireoze. Prikaz bolesnika.  U radu je prikazan papilarni
karcinom štitaste žlezde kod petnaestogodišnje devojÿice
koja je leÿena zbog kongenitalne hipotireoze od neonatal-
nog uzrasta. S obzirom na rano zapoÿinjanje i adekvatnu
supstitucionu hormonsku terapiju, normalni nivoi tireot-
ropina i tiroidnih hormona brzo su postignuti i devojÿica
je bila eutiroidna i bez simptoma do uzrasta od 13 godina i
8 meseci, kada je došlo do razvoja velike multinodularne
strume. Konsultovan je onkološki hirurg i uÿinjena je to-
talna tiroidektomija. Patohistološkim pregledom otkriven
je intratiroidni papilarni karcinom desnog režnja. Zaklju-
ÿak. Iako je diferentovani karcinom štitaste žlezde redak
pedijatrijski malignitet, od izuzetnog je znaÿaja imati odre-
Āeni stepen kliniÿke sumnje i multidisciplinarni pristup to-
kom kliniÿkog praýenja bolesnika sa dishormonogenetskim
hipotiroidizmom.
Kljuÿne reÿi:
hipotireoidizam, kongenitalni; tireoidna žlezda,
neoplazme; karcinom, papilarni; tireoidektomija; deca;
leÿenje, ishod; srbija.
Introduction
Differentiated carcinoma of the thyroid (DTC) is a rare
childhood malignancy, as it represents 0.4–3% of all pediatric
malignancies. More than 70% of these appear in patients aged
between 11 and 17 and are usually related to radiation expo-
sure.  Papillary carcinoma is the most common type of pediat-
ric DTC as it represents about 90% of all DTC cases 
1–6. Com-
pared to adults, children tend to have more aggressive clini-
cal course of this malignant disease, with up to 80% cases
presenting with regional lymph node metastasis, and pulmo-
nary metastasis in 10–20% 
1, 2, 4, 7, 8. Although rare, DTC
araising from dyshormonogenetic goiter is the most serious
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In this case report, we present the developement of thy-
roid papillary carcinoma in a 15-year-old girl diagnosed with
congenital dyshormonogenetic hypothyroidism at neonatal
age.
Case report
This 15.2-year-old girl was diagnosed with congenital
hypothyroidism as a newborn. The diagnosis of hypothy-
roidism was made by neonatal screening and the child un-
derwent further examination which confirmed the diagnosis
of primary dyshormonogenetic hypothyroidism. The patient
started substitutional levothyroxine therapy, that she contin-
ued to take regularly. Considering the early initiation and
proper dosage of hormonal substitution, normal levels of thy-
reotropin (TSH) and thyroid hormones were achieved
quickly and were present all through the follow-up. Regular
physical examinatitions showed no signs of goitre, and the
girl was euthyroid and without any simptoms until 13.8 years
of age.
At that time, the girl experienced loss of brother who
was killed in a traffic accident. Almost immediately after the
tragedy, her mother noticed the development of a large goitre
and the girl came for an unscheduled appointment. Physical
examination discovered a large multinodular goitre. Labora-
tory tests showed the following results: TSH 0.015 μIU/mL
(normal range 0.27 to 4.2 μIU/mL), fT4 12.34 pmol/L (12.0
to 22.0 pmol/L), TPO antibodies over 600 IJ/mL (normal
range less than 34 IJ/mL), Tg antibodies 140.4 IJ/mL (nor-
mal range  115 IJ/mL). Ultrasonography revealed a diffuse
enlargement of the thyroid as well as the compression of the
tracheal cartilage rings and hypoechodensity. Both of the
lobi and the isthmus contained confluent nodular masses of
15–20 mm in diameter. These laboratory and ultrasono-
graphic findings were consistent with autoimmune thyroidi-
tis. There was no enlargement of the regional lymph nodes.
At the age of 10, the girl was also diagnosed with hy-
percholesterolemia, and the family history showed that the
girl's mother and mather's father also suffered from this dis-
order. Also, the girl's grandfather had hyperthyroidism, and
underwent thyroidectomy at the age of 63.
The patient was reffered to the surgeon, who recom-
mended surgical treatment (thyroidectomy), with a complete
preoperative work-up. Chest X-ray and abdominal ultra-
sound were normal. Laboratory tests, including parathyroid
hormone and calcium levels were within allowed range. The
patient was reffered to total thyroidectomy with ex tempore
biopsy.
Pathological examination revealed the presence of in-
trathyroid papillary microcarcinoma 2.5 mm in diameter in
the right lobe. The girl had two attacks of hypocalcemic tet-
any, so she was advised to take calcium and vitamine D, as
well as substitutional levothyroxine therapy.
Currently, the girl is doing well and is euthyroid.
Data in this case report were presented with the written
consent of the patient’s parents.
Discussion
The developement of differentiated thyroid carcinoma
in patients with dyshormonogenetic goiter is very unex-
pected, especially when it comes to pediatric patients. The
case we presented was the first one the in western Serbia in
the last 30 years, since the application of the neonatal
screening program.
Most studies report a male predominance in children
under the age of 10, that shifts to a female predominance in
adolescents 
3, 8–12. As mentioned before, papillary thyroid
carcinoma is the most common form of pediatric DTC.
Although the etiology of papillary carcinoma in patients
with dishormonogenetic hypothyroidism remains unclear,
certain risk factors have been recognised. Radiation exposure
is known to be one of the major risk factors 
5, 6, 3–15. Another
important element in the development of thyroid carcinoma
is genetic factor 
9, 16. It has also been suggested that pro-
longed TSH stimulation, as well as inadequate substitutional
therapy and intermitent TSH elevation can be associated with
the development of DTC 
17, 18.
Our patient's gender and age were consistent with the
previous reports on DTC in children. On the other hand, in
the presented patient there was no radiation exposure, pre- or
postnatal, accidental or medical. Also, there were no data on
thyroid carcinoma in the patient's family history, although
her grandfather had suffered from hyperthyroidism and un-
derwent total thyroidectomy. Levothyroxine treatment was
initiated in neonatal age, the doses were adequate all the time
and the consequent TSH levels were within normal range
during the follow-up, so thyreotropin stimulation as a risk
factor can be excluded.
In pediatric population, DTC has a great 20-year sur-
vival rate, that has been reported to vary between 90 and
95%. On the other hand, it is considered to be more agressive
cancer in children, compared to adults 
1, 2, 4, 7–9.
Conclusion
Differentiated thyroid carcinoma is a rare pediatric ma-
lignant tumor and the presented patient is the only reported
case in Serbia. Although it has a more aggressive clinical
course in children than in adults, the 20-year survival rate is
excellent. Some risk factors are recognised, and should be
kept in mind when assessing patients with congenital hypo-
thyroidism. On the other hand, the presented patient did not
have any of these risks in her history, so this case can serve
as a remainder that it is of great importance to have a multi-
disciplinary approach and a certain degree of clinical suspi-
cion even in cases with no apparent risks in patients medical
history.Strana 1080 VOJNOSANITETSKI PREGLED Volumen 71, Broj 11
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